If your Brickell business has an FDA question that cannot wait — a recall, an inspection, a deadline — start with what the rules actually require. Brickell is the financial capital of Latin American trade — the banks that finance Miami’s imports, the regional headquarters that direct them, and the executives who make product and market-entry decisions for the hemisphere all sit within a few blocks. Garg Law’s Miami office is here, at 1221 Brickell Avenue, in the middle of that corridor. The companies steering FDA-regulated product lines from Brickell towers need regulatory answers at deal speed — and the office handling them is on the same street.
The short answer
A recall done well is a controlled correction; done badly it is a public unraveling. The legal work spans the decision (is this reportable, is it recallable, what class), the execution (strategy, notifications, effectiveness checks) and the aftermath — FDA follow-up, records, and the enforcement risk that mishandled recalls create.
What a recall really involves
Most recalls are “voluntary,” but the framework is FDA’s: recalls are classified Class I, II or III by health risk, executed under a written recall strategy with customer notifications, monitored through effectiveness checks, and closed only when FDA agrees disposition is complete. FDA also holds mandatory recall authority — for foods under FSMA, devices under section 518(e), and cosmetics under MoCRA — for firms that refuse to act.
The decision layer is where counsel earns its keep: whether the issue is a recall or a lesser market withdrawal, whether reporting obligations trigger — the Reportable Food Registry for foods, corrections-and-removals reporting for devices — and how the recall scope is defined so it is credible without being ruinous. These calls are made in hours, on incomplete facts, with regulators, insurers and customers all watching.
Execution is operational law: press releases and customer notices with required content, distribution-chain traceback, quarantine and disposition of returned goods, status reports to the FDA district, and the documentation that lets the recall terminate. Import-heavy businesses add a border dimension — recalled lots still arriving in containers, and supplier accountability across borders.
How Garg Law handles it
- Rapid assessment: health hazard evaluation, recall-versus-withdrawal analysis, and reporting-trigger review
- Recall strategy drafted to FDA’s framework — depth, scope, notifications, effectiveness-check level
- FDA coordination from first notification through status reports to termination
- Execution support: notices, traceback, quarantine, disposition and the records behind each
- Aftermath management — root-cause corrective actions, supplier claims, and preventing the sequel
Why Brickell manufacturers call us
The work around Brickell — international banking and trade finance, multinational regional headquarters, consumer brand offices, legal and professional services, import/export holding companies — is FDA-regulated at nearly every turn, and matters here move on Miami’s financial district, home to the banks, trade finance desks and regional headquarters that fund and direct hemispheric trade. Garg Law's Miami office is at 1221 Brickell Avenue, and the practice was built for exactly this market: founder Shelly Garg spent years counseling importers at the world's largest dedicated international trade law firm before opening her own, and works at the crossroads of FDA and CBP compliance for foreign and domestic companies across the food, beverage, supplement, cosmetics, OTC drug and medical device industries.
What not to do
- Calling it a “market withdrawal” to avoid the word recall when the facts say otherwise
- Missing the 24-hour Reportable Food Registry window while deliberating
- Scoping the recall to minimize cost instead of matching the actual risk
- Notifications that skip required content or skip levels of the distribution chain
- Declaring victory without the effectiveness checks and disposition records FDA expects
Frequently asked questions
Does FDA have to approve a recall before we start?
No — and waiting for permission is a mistake. Firms initiate voluntary recalls immediately and coordinate with FDA in parallel: classification, strategy review and status reporting. FDA involvement shapes the recall; it does not gate the first protective steps.
What is the difference between a recall and a market withdrawal?
A recall corrects a violation of FDA law; a market withdrawal addresses a minor issue involving no violation — a distinction of legal substance, not preference. Misbranding a real recall as a withdrawal is itself the kind of conduct that draws enforcement.
What is the Reportable Food Registry?
The mandatory portal for reporting foods with a reasonable probability of causing serious adverse health consequences — within 24 hours of determination. It applies to registered food facilities, the clock is short, and skipped reports surface later with consequences. The determination process should be designed before the crisis.
Can FDA force a recall if we disagree?
For foods, devices and now cosmetics, yes — mandatory recall authority exists where firms refuse and the risk justifies it. Practically, FDA’s leverage means most “voluntary” recalls are negotiated realities; counsel’s job is shaping scope and narrative inside that reality.
How does a recall end?
With FDA’s agreement to terminate: effectiveness checks done, returned product dispositioned, records complete, root cause corrected. Firms that document as they execute close recalls in months; firms that reconstruct afterward stay in recall status — publicly listed — far longer.